Inflammation and Parkinson's Disease
暂无分享,去创建一个
[1] H. Gendelman,et al. Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases , 2010, Journal of neurochemistry.
[2] N. Van Rooijen,et al. Ulcerative colitis exacerbates lipopolysaccharide‐induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease , 2010, Journal of neurochemistry.
[3] J. Nutt,et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease , 2010, Nature Genetics.
[4] C. Ferrari,et al. Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression , 2010, Journal of Neuroimmunology.
[5] V. Perry,et al. Microglia in neurodegenerative disease , 2010, Nature Reviews Neurology.
[6] D. Cadavid,et al. Bacterial lipoproteins can disseminate from the periphery to inflame the brain , 2010, The American journal of pathology.
[7] B. Jin,et al. The role of neuroinflammation on the pathogenesis of Parkinson's disease. , 2010, BMB reports.
[8] H. Gendelman,et al. Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s Disease , 2010, The Journal of Immunology.
[9] M. Goldberg,et al. Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention , 2010, Neurobiology of Disease.
[10] J. Hellemans,et al. ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain , 2009, Molecular Neurodegeneration.
[11] A. Teixeira,et al. Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease , 2009, Journal of Neuroimmunology.
[12] D. Geschwind,et al. The choroid plexus response to a repeated peripheral inflammatory stimulus , 2009, BMC Neuroscience.
[13] David Boltz,et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration , 2009, Proceedings of the National Academy of Sciences.
[14] H. Gendelman,et al. Innate and adaptive immunity for the pathobiology of Parkinson's disease. , 2009, Antioxidants & redox signaling.
[15] H. Gendelman,et al. CD 4+ T cells in the pathobiology of neurodegenerative disorders , 2009, Journal of Neuroimmunology.
[16] D. Goldemund,et al. Serum inflammatory biomarkers in Parkinson's disease. , 2009, Parkinsonism & related disorders.
[17] H. Engler,et al. Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson’s disease , 2009, Brain, Behavior, and Immunity.
[18] E. Hirsch,et al. Neuroinflammation in Parkinson's disease: a target for neuroprotection? , 2009, The Lancet Neurology.
[19] H. Stolp,et al. Review: Role of developmental inflammation and blood–brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases , 2009, Neuropathology and applied neurobiology.
[20] V. Perry,et al. Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.
[21] Y. Huang,et al. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines , 2009, Brain, Behavior, and Immunity.
[22] M. Swain,et al. Cerebral Microglia Recruit Monocytes into the Brain in Response to Tumor Necrosis Factorα Signaling during Peripheral Organ Inflammation , 2009, The Journal of Neuroscience.
[23] M. Onofrj,et al. Peripheral cytokines profile in Parkinson’s disease , 2009, Brain, Behavior, and Immunity.
[24] Y. Suh,et al. Minocycline and neurodegenerative diseases , 2009, Behavioural Brain Research.
[25] E. Hirsch,et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. , 2008, The Journal of clinical investigation.
[26] Rodney W. Johnson,et al. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system , 2008, Journal of leukocyte biology.
[27] S. Campbell,et al. Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases , 2008, Neurobiology of Disease.
[28] B. McColl,et al. Systemic Inflammation Alters the Kinetics of Cerebrovascular Tight Junction Disruption after Experimental Stroke in Mice , 2008, The Journal of Neuroscience.
[29] Lidia Glodzik-Sobanska,et al. Inflammation and Alzheimer's disease: Possible role of periodontal diseases , 2008, Alzheimer's & Dementia.
[30] C. Ferrari,et al. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease , 2008, Brain : a journal of neurology.
[31] V. Perry,et al. Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration , 2008, Neurobiology of Disease.
[32] M. Sawada,et al. Effects of Aging on Neuroprotective and Neurotoxic Properties of Microglia in Neurodegenerative Diseases , 2008, Neurodegenerative Diseases.
[33] J. Chen,et al. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system , 2008, Brain, Behavior, and Immunity.
[34] O. Isacson,et al. Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease , 2008, Journal of Neuroinflammation.
[35] B. Zlokovic. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.
[36] H. Gendelman,et al. Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease , 2007 .
[37] M. Tansey,et al. Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention , 2007, Experimental Neurology.
[38] M. O’Banion,et al. Chronic Interleukin-1β Expression in Mouse Brain Leads to Leukocyte Infiltration and Neutrophil-Independent Blood–Brain Barrier Permeability without Overt Neurodegeneration , 2007, The Journal of Neuroscience.
[39] S. Campbell,et al. Overexpression of IL-1β by adenoviral-mediated gene transfer in the rat brain causes a prolonged hepatic chemokine response, axonal injury and the suppression of spontaneous behaviour , 2007, Neurobiology of Disease.
[40] I. Clark,et al. The advent of the cytokine storm , 2007, Immunology and cell biology.
[41] J. Sinsheimer,et al. Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease. , 2007, Archives of neurology.
[42] Q. Pittman,et al. Peripheral Inflammation Exacerbates Damage After Global Ischemia Independently of Temperature and Acute Brain Inflammation , 2007, Stroke.
[43] Colm Cunningham,et al. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) , 2007, Brain, Behavior, and Immunity.
[44] B. McColl,et al. Systemic Inflammatory Stimulus Potentiates the Acute Phase and CXC Chemokine Responses to Experimental Stroke and Exacerbates Brain Damage via Interleukin-1- and Neutrophil-Dependent Mechanisms , 2007, The Journal of Neuroscience.
[45] P S Whitton,et al. Inflammation as a causative factor in the aetiology of Parkinson's disease , 2007, British journal of pharmacology.
[46] F. Crews,et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.
[47] Colm Cunningham,et al. Systemic infections and inflammation affect chronic neurodegeneration , 2007, Nature Reviews Immunology.
[48] C. Ferrari,et al. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1β in the substantia nigra , 2006, Neurobiology of Disease.
[49] B. Botterman,et al. Blocking Soluble Tumor Necrosis Factor Signaling with Dominant-Negative Tumor Necrosis Factor Inhibitor Attenuates Loss of Dopaminergic Neurons in Models of Parkinson's Disease , 2006, The Journal of Neuroscience.
[50] Y. Mizuno,et al. Inflammation and infection in Parkinson's disease. , 2006, Histology and histopathology.
[51] J. Miklossy,et al. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys , 2006, Experimental Neurology.
[52] Eric Jacobs,et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease , 2005, Annals of neurology.
[53] R. Uitti,et al. Alterations of T-lymphocyte populations in Parkinson disease. , 2005, Parkinsonism & related disorders.
[54] V. Perry,et al. Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.
[55] P. Carvey,et al. 6‐Hydroxydopamine‐induced alterations in blood–brain barrier permeability , 2005, The European journal of neuroscience.
[56] J. de Vellis,et al. Microglia in health and disease , 2005, Journal of neuroscience research.
[57] Jing Chen,et al. Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[58] S. Brandt,et al. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[59] V. Perry,et al. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. , 2005, The American journal of pathology.
[60] R. Dobbs,et al. Role of inflammation in gastrointestinal tract in aetiology and pathogenesis of idiopathic parkinsonism. , 2005, FEMS immunology and medical microbiology.
[61] Colm Cunningham,et al. Comparison of Inflammatory and Acute-Phase Responses in the Brain and Peripheral Organs of the ME7 Model of Prion Disease , 2005, Journal of Virology.
[62] N. Quan,et al. IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system , 2005, Brain, Behavior, and Immunity.
[63] J. Bart,et al. Blood–brain barrier dysfunction in parkinsonian midbrain in vivo , 2005, Annals of neurology.
[64] E. Hirsch,et al. Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian , 2005, Journal of Neural Transmission.
[65] S. Leurgans,et al. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally , 2004, Experimental Neurology.
[66] V. Perry,et al. Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. , 2004, The American journal of pathology.
[67] Robert Dantzer,et al. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. , 2004, European journal of pharmacology.
[68] V. Perry. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease , 2004, Brain, Behavior, and Immunity.
[69] J. Cano,et al. Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood–brain barrier, and damage in the nigral dopaminergic system , 2004, Neurobiology of Disease.
[70] E. Yan,et al. Cerebrovascular Responses in the Fetal Sheep Brain to Low-Dose Endotoxin , 2004, Pediatric Research.
[71] H. Przuntek,et al. Diagnostic staging of Parkinson’s disease: conceptual aspects , 2004, Journal of Neural Transmission.
[72] C. Ferrari,et al. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease , 2003, The European journal of neuroscience.
[73] P. Carvey,et al. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. , 2003, Frontiers in bioscience : a journal and virtual library.
[74] W. Willett,et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. , 2003, Archives of neurology.
[75] J. Iredale,et al. CINC‐1 is identified as an acute‐phase protein induced by focal brain injury causing leukocyte mobilization and liver injury , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[76] M. Vila,et al. COX‐2 and Neurodegeneration in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.
[77] Dong-Kug Choi,et al. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[78] J. Oxford,et al. Lack of detection of influenza genes in archived formalin-fixed, paraffin wax-embedded brain samples of encephalitis lethargica patients from 1916 to 1920. , 2003, Virchows Archiv.
[79] Colm Cunningham,et al. The impact of systemic infection on the progression of neurodegenerative disease , 2003, Nature Reviews Neuroscience.
[80] G. Bing,et al. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration , 2003, Neurobiology of Disease.
[81] Kevin J. Tracey,et al. The inflammatory reflex , 2002, Nature.
[82] V. Perry,et al. Altered chemokine expression in the spinal cord and brain contributes to differential interleukin‐1β‐induced neutrophil recruitment , 2002, Journal of neurochemistry.
[83] Andrzej Członkowski,et al. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide. , 2002, Medical science monitor : international medical journal of experimental and clinical research.
[84] A. Członkowska,et al. Indomethacin protects against neurodegeneration caused by MPTP intoxication in mice. , 2002, International immunopharmacology.
[85] C. Cunningham,et al. Atypical inflammation in the central nervous system in prion disease , 2002, Current opinion in neurology.
[86] T. Hirayama,et al. Cutting Edge: VacA, a Vacuolating Cytotoxin of Helicobacter pylori, Directly Activates Mast Cells for Migration and Production of Proinflammatory Cytokines1 , 2002, The Journal of Immunology.
[87] P. Mander,et al. Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration , 2002, Neuroscience.
[88] V. Perry,et al. The Systemic and Local Acute Phase Response following Acute Brain Injury , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[89] G. Raivich,et al. Systemic LPS Injection Leads to Granulocyte Influx into Normal and Injured Brain: Effects of ICAM-1 Deficiency , 2001, Experimental Neurology.
[90] Y. Itoyama,et al. Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease. , 2001, Archives of neurology.
[91] J. Koistinaho,et al. Minocycline Provides Neuroprotection Against N-Methyl-d-aspartate Neurotoxicity by Inhibiting Microglia1 , 2001, The Journal of Immunology.
[92] S. Ambrosio,et al. Lymphocyte populations in Parkinson’s disease and in rat models of parkinsonism , 2001, Journal of Neuroimmunology.
[93] M. Beyer,et al. Causes of death in a community‐based study of Parkinson's disease , 2001, Acta neurologica Scandinavica.
[94] A. Suzumura,et al. Impaired cytokine production by peripheral blood mononuclear cells and monocytes/macrophages in Parkinson's disease , 2000, Acta neurologica Scandinavica.
[95] R. Dobbs,et al. Association of circulating TNF‐α and IL‐6 with ageing and parkinsonism , 1999 .
[96] S. Maier,et al. Interleukin-1β in Immune Cells of the Abdominal Vagus Nerve: a Link between the Immune and Nervous Systems? , 1999, The Journal of Neuroscience.
[97] P. Ernst,et al. Review article: the role of inflammation in the pathogenesis of gastric cancer , 1999, Alimentary pharmacology & therapeutics.
[98] A. Terano,et al. Chemokine expression in Helicobacter pylori-infected gastric mucosa , 1998, Journal of Gastroenterology.
[99] R. Dantzer,et al. Cytokines and Sickness Behavior , 1998, Annals of the New York Academy of Sciences.
[100] J. Krueger,et al. Vagotomy Blocks the Induction of Interleukin-1β (IL-1β) mRNA in the Brain of Rats in Response to Systemic IL-1β , 1998, The Journal of Neuroscience.
[101] F. Pitossi,et al. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice , 1997, Journal of neuroscience research.
[102] G. Nieuwenhuijzen,et al. Elimination of various subpopulations of macrophages and the development of multiple-organ dysfunction syndrome in mice. , 1997, Archives of surgery.
[103] V. Perry,et al. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. , 1997, Brain : a journal of neurology.
[104] R. Dantzer,et al. Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. , 1996, Neuroreport.
[105] G. Kreutzberg. Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.
[106] R. Dantzer,et al. Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. , 1996, Neuroreport.
[107] T. Nagatsu,et al. Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease , 1996, Neuroscience Letters.
[108] T. K. van den Berg,et al. Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. , 1996, Journal of immunological methods.
[109] H. Besedovsky,et al. Immune-neuro-endocrine interactions: facts and hypotheses. , 1996, Endocrine reviews.
[110] Peter Riederer,et al. Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients , 1995, Neuroscience Letters.
[111] P. Riederer,et al. Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients , 1994, Neuroscience Letters.
[112] F. Mégraud,et al. Epidemiology of Helicobacter pylori infection. , 1993, Gastroenterology clinics of North America.
[113] M. Kluger. Fever: Role of Pyrogens and Cryogens , 1991, Physiological reviews.
[114] N. Rooijen. The liposome-mediated macrophage ‘suicide’ technique , 1989 .
[115] P. Mcgeer,et al. Major histocompatibility complex antigen expression on rat microglia following epidural kainic acid lesions , 1988, Journal of neuroscience research.
[116] B. Marshall,et al. UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS , 1983, The Lancet.
[117] W. Foege,et al. 1918 INFLUENZA, ENCEPHALITIS LETHARGICA, PARKINSONISM , 1982, The Lancet.
[118] R. Dantzer,et al. Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .
[119] P. Ragonese,et al. Long–term survival of Parkinson's disease , 2005, Journal of Neurology.
[120] Gavin Giovannoni,et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. , 2004, Brain : a journal of neurology.
[121] F. Hattori,et al. Japanese encephalitis and parkinsonism , 2004, Journal of Neurology.
[122] P. Carvey,et al. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain , 2002, Movement disorders : official journal of the Movement Disorder Society.
[123] R. Peek. Microbes and microbial toxins : Paradigms for microbial-mucosal interactions. IV. Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation , 2001 .
[124] G. Levi,et al. Possible role of microglial prostanoids and free radicals in neuroprotection and neurodegeneration. , 1999, Advances in experimental medicine and biology.
[125] R. Dantzer,et al. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.